NCT02635542View on ClinicalTrials.gov

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 15, 2017

Study Completion Date

September 15, 2017

Conditions
Neuromuscular BlockadePostoperative Complications
Interventions
DRUG

Succinylcholine

Succinylcholine will be used to facilitate endotracheal intubation for general anesthesia in the operating room. No additional neuromuscular blockade will be provided during general anesthesia.

DRUG

Cisatracurium

Cisatracurium will be used to maintain neuromuscular blockade during general anesthesia.

Trial Locations (1)

60637

University of Chicago Medicine, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT02635542 - Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery | Biotech Hunter | Biotech Hunter